|
202
|
552
|
5f19A |
The crystal structure of aspirin acetylated human cyclooxygenase-2 |
|
12
|
55
|
4z0kB |
Rapid development of two factor ixa inhibitors from hit to lead |
|
207
|
551
|
5fdqA |
Murine cox-2 s530t mutant |
|
7
|
43
|
5e8dA |
Crystal structure of human epiregulin in complex with the fab fragment of murine monoclonal antibody 9e5 |
|
12
|
55
|
4zaeB |
Development of a novel class of potent and selective fixa inhibitors |
|
11
|
54
|
5egmB |
Development of a novel tricyclic class of potent and selective fixa inhibitors |
|
13
|
55
|
4yt6L |
Factor viia in complex with the inhibitor 4-{[(r)-[5-ethoxy-2-fluoro-3-(propan-2-yloxy)phenyl](4-phenyl-1h-imidazol-2-yl)methyl]amino}benzenecarboximidamide |
|
177
|
552
|
5coxA |
Uninhibited mouse cyclooxygenase-2 (prostaglandin synthase-2) |
|
13
|
57
|
4yzuB |
Rapid development of two factor ixa inhibitors from hit to lead |
|
51
|
277
|
5ckmA |
The cub1-egf-cub2 domains of rat mbl-associated serine protease-2 (masp-2) bound to ca2+ |
|
40
|
276
|
5ckqA |
Cub1-egf-cub2 domains of rat masp-1 |
|
12
|
52
|
4y71B |
Factor xa complex with gtc000398 |
|
12
|
55
|
4x8tL |
Factor viia in complex with the inhibitor 7-chloro-3,4-dihydroisoquinolin-1(2h)-one |
|
12
|
52
|
4y6dB |
Factor xa complex with gtc000101 |
|
12
|
53
|
4y7bB |
Factor xa complex with gtc000441 |
|
38
|
270
|
4xbmA |
X-ray crystal structure of notch ligand delta-like 1 |
|
12
|
53
|
4y79B |
Factor xa complex with gtc000406 |
|
17
|
113
|
4xlwA |
Complex of notch1 (egf11-13) bound to delta-like 4 (n-egf2) |
|
13
|
53
|
4y7aB |
Factor xa complex with gtc000422 |
|
18
|
115
|
4xl1A |
Complex of notch1 (egf11-13) bound to delta-like 4 (n-egf1) |
|
12
|
53
|
4y76B |
Factor xa complex with gtc000401 |
|
13
|
55
|
4x8sL |
Factor viia in complex with the inhibitor 4-bromo-2-methoxyphenol |
|
12
|
55
|
4x8vL |
Factor viia in complex with the inhibitor (methyl {3-[(2r)-1-{(2r)-2-(3,4-dimethoxyphenyl)-2-[(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)amino]acetyl}pyrrolidin-2-yl]-4-(propan-2-ylsulfonyl)phenyl}carbamate) |
|
10
|
55
|
4x8uL |
Factor viia in complex with the inhibitor 5-chloro-1h-indole-2-carboxylic acid |
|
199
|
552
|
4rutA |
Crystal structure of murine cyclooxygenase-2 with 13-methyl-arachidonic acid |
|
200
|
552
|
4rrwA |
Crystal structure of apo murine cyclooxygenase-2 |
|
187
|
552
|
4rrxA |
Crystal structure of apo murine v89w cyclooxygenase-2 complexed with lumiracoxib |
|
2
|
50
|
4tgfA |
Solution structures of human transforming growth factor alpha derived from 1*h nmr data |
|
200
|
552
|
4rrzA |
Crystal structure of apo murine h90w cyclooxygenase-2 complexed with lumiracoxib |
|
197
|
552
|
4rryA |
Crystal structure of apo murine h90w cyclooxygenase-2 |
|
202
|
557
|
4rs0A |
Crystal structure of murine h90w cyclooxygenase-2 complexed with s-ibuprofen |
|
206
|
551
|
4ph9A |
The structure of ibuprofen bound to cyclooxygenase-2 |
|
200
|
552
|
4otjA |
The complex of murine cyclooxygenase-2 with a conjugate of indomefathin and podophyllotoxin, n-{(succinylpodophyllotoxinyl)but-4-yl}-2-{1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indol-3-yl}acetamide |
|
197
|
552
|
4otyA |
Crystal structure of lumiracoxib bound to the apo-mouse-cyclooxygenase-2 |
|
197
|
553
|
4o1zA |
Crystal structure of ovine cyclooxygenase-1 complex with meloxicam |
|
13
|
55
|
4ngaL |
Factor viia in complex with the inhibitor (2r)-2-[(1-aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(propan-2-yloxy)phenyl]-n-[2-(propan-2-ylsulfonyl)benzyl]ethanamide |
|
117
|
687
|
4o02B |
Alphavbeta3 integrin in complex with monoclonal antibody fab fragment. |
|
12
|
55
|
4na9L |
Factor viia in complex with the inhibitor 3'-amino-5'-[(2s,4r)-6-carbamimidoyl-4-phenyl-1,2,3,4-tetrahydroquinolin-2-yl]biphenyl-2-carboxylic acid |
|
12
|
55
|
4ng9L |
Factor viia in complex with the inhibitor (2r)-2-[(1-aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(propan-2-yloxy)phenyl]-n-(3-sulfamoylbenzyl)ethanamide |
|
142
|
690
|
4mmyB |
Integrin alphavbeta3 ectodomain bound to the tenth domain of fibronectin with the iakgdwnd motif |
|
51
|
276
|
4lmfA |
C1s cub1-egf-cub2 |
|
195
|
552
|
4m11A |
Crystal structure of murine cyclooxygenase-2 complex with meloxicam |
|
146
|
690
|
4mmzB |
Integrin alphavbeta3 ectodomain bound to an antagonistic tenth domain of fibronectin |
|
50
|
276
|
4lorA |
C1s cub1-egf-cub2 in complex with a collagen-like peptide from c1q |
|
209
|
552
|
4m10A |
Crystal structure of murine cyclooxygenase-2 complex with isoxicam |
|
136
|
690
|
4mmxB |
Integrin alphavbeta3 ectodomain bound to the tenth domain of fibronectin |
|
13
|
55
|
4jzdL |
Structure of factor viia in complex with the inhibitor 2-{2-[(4-carbamimidoylphenyl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2s)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid |
|
12
|
55
|
4ishL |
Structure of factor viia in complex with the inhibitor bms-593214 also known as 2'-[(6r,6ar,11br)-2-carbamimidoyl-6,6a,7,11b-tetrahydro-5h-indeno[2,1-c]quinolin-6-yl]-5'-hydroxy-4'-methoxybiphenyl-4-carboxylic acid |
|
11
|
55
|
4jzeL |
Structure of factor viia in complex with the inhibitor 2-{2-[(1-aminoisoquinolin-6-yl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2s)-1-hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic acid |
|
12
|
55
|
4isiL |
Structure of factor viia in complex with the inhibitor (6s)-n-(4-carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,8-diethyl-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide |
